MedTrace Logo

Chemotherapy Plus Reduced Radiotherapy in Intracranial Germinoma

NCT02782754 · Status: UNKNOWN · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 40

Last updated 2016-05-25

No results posted yet for this study

Summary

The purpose of this study is to evaluate the outcome of intracranial germinoma treated with chemotherapy plus reduced radiotherapy.

Conditions

  • Intracranial Germinoma

Interventions

DRUG

Carboplatin

DRUG

Etoposide

DRUG

Cyclophosphamide

DRUG

Bleomycin

RADIATION

Reduced dose of radiotherapy

Sponsors & Collaborators

  • Samsung Medical Center

    lead OTHER

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
3 Years
Max Age
30 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2013-01-31
Primary Completion
2017-12-31

Countries

  • South Korea

Study Locations

More Related Trials

Entities

Drugs

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02782754 on ClinicalTrials.gov